N. Zein
Epidemiology · 2006–2010
A researcher in the Science corpus: 4 papers; trusts 1 researcher and is trusted by 1 researcher here, as inferred from the citation graph.
Subfields
- Epidemiology — 26 citations into it; #1,715 of 2,148 by trust here, #626 by citations
Whom N. Zein trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- H. B. EL‐SERAG (in Epidemiology)
Who trusts N. Zein
- Megan H. Bair-Merritt (in Epidemiology)
Papers from N. Zein's perspective
Ordered by how strongly the researchers N. Zein trusts endorse each paper. Same corpus, a different order for every researcher.
- The natural history of nonalcoholic fatty liver disease: a population-based cohort study. (Gastroenterology)
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease (Hepatology)
- Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. (Nature Medicine)
- Inflammation: the link between insulin resistance, obesity and diabetes. (Trends in immunology)
- The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. (Clinical Gastroenterology and Hepatology)
- Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study (Gut)
- Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. (Gastroenterology)
- Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. (New England Journal of Medicine)
- NAFLD may be a common underlying liver disease in patients with hepatocellular Carcinoma in the United States (Hepatology)
- Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. (Gastroenterology)
Their papers
- The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis (2010) — 1,248 citations
- Cytokeratin-18 fragment levels as noninvasive biomarker for nonalcoholic steatohepatitis: A multicenter validation study (2009) — 719 citations
- Increased Hepatic and Circulating Interleukin-6 Levels in Human Nonalcoholic Steatohepatitis (2008) — 603 citations
- In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease (2006) — 697 citations